Insiders who reported open-market trades in the last 12 months at the companies Donald H. Picker files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Donald H. Picker is a corporate insider, tracked as Chief Science Officer of Moleculin Biotech, Inc. (MBRX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Donald H. Picker submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Donald H. Picker been buying or selling stock?
Recorded transactions: 2 open-market purchases and 0 open-market sales across all tracked filings.
Donald H. Picker is Chief Science Officer of Moleculin Biotech, Inc. (MBRX). 7 SEC Form 4 filings on record going back to 2024, most recently on 17 October 2026.
Recent transactions
11
The latest 11 SEC Form 4 transactions reported by Donald H. Picker.
InsiderAlpha's records for Donald H. Picker go back to 2024: 7 primary Form 4 filings, an average of 2.3 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
